HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention.

Abstract
Prospective data were collected from 743 consecutive patients with ST-segment elevation acute myocardial infarctions (AMIs) treated with primary percutaneous coronary intervention (mean age 65.3 +/- 11.6 years, 36.7% women). Early post-AMI pericarditis was diagnosed in 31 patients (4.2%; mean age 62.1 +/- 13.4 years, 41.9% women), with an increasing prevalence according to presentation delay (p <0.001): 1.7% for <3 hours, 5.4% for 3 to 6 hours, and 13.6% for >6 hours. Late post-AMI pericarditis (Dressler syndrome) was recorded in only 1 patient (0.1%). On multivariate analysis, patients with presentation times >6 hours (odds ratio 4.4, 95% confidence interval 2.0 to 9.8, p <0.001) and primary percutaneous coronary intervention failure (odds ratio 2.8, 95% confidence interval 1.1 to 7.4, p = 0.032) were at increased risk for developing early post-AMI pericarditis. Although pericarditis is associated with a larger infarct size, in-hospital and 1-year mortality and major adverse cardiac events were similar in patients with and without pericarditis. In conclusion, early primary percutaneous coronary intervention may reduce the occurrence of early post-AMI pericarditis within the first 3 hours of symptom onset. Early post-AMI pericarditis remains a marker of larger infarct size but without independent prognostic significance.
AuthorsMassimo Imazio, Alessandro Negro, Riccardo Belli, Federico Beqaraj, Davide Forno, Massimo Giammaria, Rita Trinchero, Yehuda Adler, David Spodick
JournalThe American journal of cardiology (Am J Cardiol) Vol. 103 Issue 11 Pg. 1525-9 (Jun 01 2009) ISSN: 1879-1913 [Electronic] United States
PMID19463510 (Publication Type: Journal Article)
Topics
  • Aged
  • Angioplasty, Balloon, Coronary
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (complications, mortality, pathology, therapy)
  • Pericarditis (epidemiology, etiology)
  • Prevalence
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: